PD13-01 LOSS OF FOXA1 EXPRESSION IS ASSOCIATED WITH ADVERSE PATHOLOGIC FEATURES AND INFERIOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY

Lauren Shuman , Joshua Warrick , David Degraff , Shahrokh Shariat , Jose Karam , Christopher Wood (1) , Alon Weizer (2) , Mesut Remzi (3) , Andrea Haitel (4) , Karim Bensalah (5, 6) , Nathalie Rioux-Leclercq (7) , Christian Bolenz (8) , Marco Roscigno , Laura-Maria Krabbe (9) , Payal Kapur (9) , Yair Lotan (9) , Vitaly Margulis (9) , Jay Raman (10)

1 MD Anderson Cancer Center
2 University of Michigan [Ann Arbor]
3 Department of Urology
4 Medizinische Universität Wien = Medical University of Vienna
5 Service d'urologie [Rennes] = Urology [Rennes]
6 LTSI - Laboratoire Traitement du Signal et de l'Image
7 IGDR - Institut de Génétique et Développement de Rennes
8 Mannheim Medical Center
9 Department of Urology
10 Department of Urologic Oncology

no abstract

Domaines: Sciences du Vivant [q-bio]

Lauren Shuman, Joshua Warrick, David Degraff, Shahrokh Shariat, Jose Karam, et al.. PD13-01 LOSS OF FOXA1 EXPRESSION IS ASSOCIATED WITH ADVERSE PATHOLOGIC FEATURES AND INFERIOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY. Journal of Urology, 2016, 2016 Annual Meeting Program Abstracts AUA Annual Meeting, 195 (4, Supplement), pp.e298. ⟨10.1016/j.juro.2016.02.972⟩. ⟨hal-01300790⟩